Metformin Reduces The Risk of Developing Long Term Covid 19 Symptoms Study Finds
Treating COVID with Metformin In a groundbreaking study published in Lancet Infectious Diseases, researchers have found that metformin, a widely available and affordable diabetes drug, could potentially reduce the incidence of long COVID when administered during the acute phase of COVID-19. This randomised controlled trial demonstrated that a two-week course of metformin, initiated within three…
